{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:30:05Z","timestamp":1784140205946,"version":"3.55.0"},"reference-count":50,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2019,5,31]],"date-time":"2019-05-31T00:00:00Z","timestamp":1559260800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2019,9]]},"abstract":"<jats:p>Linked pharmacometric and pharmacoeconomic models provide a structured approach for assessing the value of candidate drugs in development. The aim of this study was to assess the utility of such an approach for identifying the properties of xanthine oxidase inhibitors (<jats:styled-content style=\"fixed-case\">XO<\/jats:styled-content>i) providing improved forgiveness to nonadherence and estimate the maximum reimbursement price. The pharmacometric and pharmacoeconomic models were used to simulate the time course of serum uric acid concentrations and estimate quality\u2010adjusted life years and costs for the <jats:styled-content style=\"fixed-case\">XO<\/jats:styled-content>i febuxostat and a range of hypothetical analogues. Compounds with reduced clearance or increased potency were more forgiving to missed doses, however, even following relatively large changes in these properties the predicted maximum reimbursement prices represented an increase of only 19% above febuxostat 80\u00a0mg. Linked pharmacometric and pharmacoeconomic modeling methods have the potential to inform early drug development by providing an indication of pricing options that may permit reimbursement.<\/jats:p>","DOI":"10.1002\/cpt.1454","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T02:02:36Z","timestamp":1555466556000},"page":"652-660","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for Gout"],"prefix":"10.1111","volume":"106","author":[{"given":"Daniel","family":"Hill\u2010McManus","sequence":"first","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation Bangor University  Bangor UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Marshall","sequence":"additional","affiliation":[{"name":"Pharmacometrics Pfizer Ltd  Sandwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Soto","sequence":"additional","affiliation":[{"name":"Pharmacometrics Pfizer Ltd  Sandwich UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dyfrig A.","family":"Hughes","sequence":"additional","affiliation":[{"name":"Centre for Health Economics and Medicines Evaluation Bangor University  Bangor UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2019,5,31]]},"reference":[{"key":"e_1_2_10_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2018.06.002"},{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.07.006"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2014.03.1721"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.2165\/11591540-000000000-00000"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199222030-00006"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2008.03124.x"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13427"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.12275"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-017-01352-3"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12559"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pharmtox-011711-113247"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2012.04167.x"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2010.171"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.268"},{"key":"e_1_2_10_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40268-017-0216-6"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00091-2"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa050373"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.24209"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.080814"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.39840"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-209213"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.1080\/00325481.2016.1113840"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2296-14-170"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kex521"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017542"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.09.007"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2017.04.031"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.4"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfx036"},{"key":"e_1_2_10_30_1","unstructured":"National Institute for Health and Care Excellence.Final appraisal determination: Pegloticase for treating severe debilitating chronic tophaceous gout<https:\/\/www.nice.org.uk\/guidance\/ta291;> (2013)."},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1002\/psp4.48"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.190"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/bcp.13229"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1177\/0091270004274433"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2013.54"},{"key":"e_1_2_10_36_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10198-014-0617-1"},{"key":"e_1_2_10_37_1","doi-asserted-by":"publisher","DOI":"10.3111\/13696998.2016.1149482"},{"key":"e_1_2_10_38_1","unstructured":"National Institute for Health and Care Excellence.Single technology appraisal [ID761]: Lesinurad for treating chronic hyperuricaemia in people with gout Committee Papers. (2016)."},{"key":"e_1_2_10_39_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j2376"},{"key":"e_1_2_10_40_1","unstructured":"Joint Formulary Committee.British national formulary (online).London:BMJ Group and Pharmaceutical Press<bnf.nice.org.uk> (2018)."},{"key":"e_1_2_10_41_1","unstructured":"National Institute for Health and Care Excellence.Guide to the single technology appraisal process<https:\/\/www.nice.org.uk> (2009)."},{"key":"e_1_2_10_42_1","unstructured":"National Institute for Health and Care Excellence.Guide to the methods of technology appraisal 2013<nice.org.uk\/process\/pmg9\u00a0>\u00a0(2013)."},{"key":"e_1_2_10_43_1","unstructured":"R Core Team.R: A language and environment for statistical computing.R Foundation for Statistical Computing<https:\/\/www.r-project.org\/> (2017)."},{"key":"e_1_2_10_44_1","unstructured":"The Office for National Statistics England and Wales 2015.2015. National life tables UK<https:\/\/www.ons.gov.uk\/peoplepopulationandcommunity\/birthsdeathsandmarriages\/lifeexpectancies> (2015)."},{"key":"e_1_2_10_45_1","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7525-10-117"},{"key":"e_1_2_10_46_1","doi-asserted-by":"publisher","DOI":"10.1191\/096228099669221405"},{"key":"e_1_2_10_47_1","first-page":"33","article-title":"Monitoring one\u2010year compliance to antihypertension medication in the Seychelles","volume":"80","author":"Bovet P.","year":"2002","journal-title":"Bull World Health Organ."},{"key":"e_1_2_10_48_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-199732050-00001"},{"key":"e_1_2_10_49_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20405"},{"key":"e_1_2_10_50_1","doi-asserted-by":"publisher","DOI":"10.2165\/00019053-200826090-00004"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.1454","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.1454","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.1454","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:30:34Z","timestamp":1699363834000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.1454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,31]]},"references-count":50,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["10.1002\/cpt.1454"],"URL":"https:\/\/doi.org\/10.1002\/cpt.1454","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,5,31]]},"assertion":[{"value":"2019-01-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-03-04","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-05-31","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}